Title

Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.

Document Type

Article

Publication Date

2-1-2015

Publication Title

Neuro Oncol

Abstract

Glioblastoma is the most common primary brain malignancy and is associated with poor prognosis despite aggressive local and systemic therapy, which is related to a paucity of viable treatment options in both the newly diagnosed and recurrent settings. Even so, the rapidly increasing number of targeted therapies being evaluated in oncology clinical trials offers hope for the future. Given the broad range of possibilities for future trials, the Brain Malignancy Steering Committee convened a clinical trials planning meeting that was held at the Udvar-Hazy Center in Chantilly, Virginia, on September 19 and 20, 2013. This manuscript reports the deliberations leading up to the event from the Targeted Therapies Working Group and the results of the meeting.

Medical Subject Headings

Biomarkers; Brain Neoplasms; Clinical Trials as Topic; Endpoint Determination; Glioblastoma; Humans

PubMed ID

25165194

Volume

17

Issue

2

First Page

180

Last Page

188

Share

COinS